Davis John M, Moder Kevin G, Homburger Henry A, Ytterberg Steven R
From Division of Rheumatology (JMD, KGM, SRY), Department of Medicine; Division of Clinical Biochemistry and Immunology (HAH), Department of Laboratory Medicine and Pathology; Mayo Clinic College of Medicine and Mayo Clinic, Rochester, Minnesota.
Medicine (Baltimore). 2005 Jul;84(4):208-217. doi: 10.1097/01.md.0000173181.87969.eb.
Systemic lupus erythematosus (SLE) rarely presents with a negative antinuclear antibody (ANA). Although antibodies to extractable nuclear antigens (ENA) are sometimes ordered despite a negative ANA, it is unclear if this contributes to the diagnosis of SLE or other forms of connective tissue disease (CTD). We reviewed 39 patients with anti-ENA antibodies despite a negative ANA during a 1-year period to determine the presence of SLE or other CTD. Several patients had clinical features suggestive of CTD, including 1 with possible SLE. A number of patients had neurologic disorders, especially peripheral neuropathy. In this study, the finding of anti-ENA despite negative ANA was associated with neurologic disorders and CTD. This may represent test bias or false-positive anti-ENA assays or false-negative ANA assays, or may imply immune-related mechanisms not previously described.
系统性红斑狼疮(SLE)很少出现抗核抗体(ANA)阴性的情况。尽管有时在ANA阴性时仍会检测可提取核抗原(ENA)抗体,但尚不清楚这是否有助于SLE或其他形式的结缔组织病(CTD)的诊断。我们回顾了在1年期间ANA阴性但有抗ENA抗体的39例患者,以确定是否存在SLE或其他CTD。部分患者具有提示CTD的临床特征,其中1例可能患有SLE。一些患者患有神经系统疾病,尤其是周围神经病变。在本研究中,ANA阴性但抗ENA阳性的结果与神经系统疾病和CTD相关。这可能代表检测偏倚、抗ENA检测假阳性或ANA检测假阴性,或者可能意味着存在先前未描述的免疫相关机制。